一种基于贝鲁龙酸的化合物的肝激活活性
K I Mosalev1, I D Ivanov1, M V Tenditnik2
1Federal Research Center for Fundamental and Translational Medicine, Novosibirsk, Russia.
Biomeditsinskaia khimiia
|March 7, 2024
概括
这项研究研究了BABC的肝脏效应,BABC是一种新型化合物,在免疫抑制小鼠中. BABC改变了基因和蛋白质表达,包括增加了CYP 2B10和促炎细胞因子,表明潜在的肝发育活性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
背景情况:
- 环胺 (CP) 是一种广泛使用的化学疗法剂,可诱导免疫抑制.
- 了解新型化合物的肝发性作用对于药物开发至关重要.
- 贝图龙酸结合物正在被探索,以寻找它们的治疗潜力.
研究的目的:
- 为了研究一种新型结合物BABC在小鼠CP诱导免疫抑制模型中的肝发性作用.
- 分析BABC对肝脏基因和蛋白质表达的影响,包括细胞染色体,PPARA和细胞因子.
- 评估NF-κB p65,GST-π和NAT-1等关键信号蛋白的调制.
主要方法:
- C57BL/6小鼠接受了CP治疗以诱导免疫抑制.
- 结合BABC被给予了CP治疗的小鼠和完整的小鼠.
- 使用定量方法分析肝脏组织的基因表达 (CYP酶,PPARA,细胞因子) 和蛋白质水平 (NF-κB p65,GST-π,NAT-1).
主要成果:
- 在接受CP治疗的小鼠中,BABC的使用显著增加了CYP 2B10的表达 (3.2倍).
- 在接受BABC和CP治疗的小鼠中观察到TNF-αmRNA的2.4倍增加.
- 在完整的小鼠中,BABC治疗导致IL-1β增加 (2.5倍),IL-10表达减少 (1.8倍),NF-κB p65 (1.6倍) 和NAT-1 (2.7倍) 蛋白水平升高.
结论:
- 结合BABC在小鼠中表现出显著的肝发性作用,调节细胞和细胞因子的表达.
- BABC影响炎症通路,由增加的促炎细胞因子和NF-κB p65激活表明.
- 这些发现凸显了BABC作为治疗剂的潜力,需要进一步研究其机制和安全性.
相关概念视频
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
198
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
198
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K


